KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 117 filers reported holding KYMERA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,700 | -39.3% | 1,705 | +0.4% | 0.00% | – |
| Q2 2023 | $39,060 | +78020.0% | 1,699 | 0.0% | 0.00% | – |
| Q1 2023 | $50 | -3.8% | 1,699 | -17.9% | 0.00% | – |
| Q4 2022 | $52 | -99.9% | 2,069 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $63,000 | +50.0% | 2,069 | -3.2% | 0.00% | – |
| Q2 2022 | $42,000 | +100.0% | 2,137 | +338.8% | 0.00% | – |
| Q1 2022 | $21,000 | -59.6% | 487 | -60.3% | 0.00% | – |
| Q4 2021 | $52,000 | +13.0% | 1,227 | +57.3% | 0.00% | – |
| Q3 2021 | $46,000 | -54.9% | 780 | -62.8% | 0.00% | -100.0% |
| Q2 2021 | $102,000 | +24.4% | 2,098 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $82,000 | -36.9% | 2,098 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $130,000 | – | 2,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |